Michael Joseph Golembiewski - 01 Sep 2021 Form 3 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Issuer symbol
N/A
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
3
Filing time
02 Sep 2021, 16:03:06 UTC
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SEEL Common Stock 65,987 01 Sep 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SEEL Stock option (right to buy) 01 Sep 2021 Common Stock 62,500 $2.20 Direct F1
holding SEEL Stock option (right to buy) 01 Sep 2021 Common Stock 100,000 $1.42 Direct F2
holding SEEL Stock option (right to buy) 01 Sep 2021 Common Stock 312,211 $1.08 Direct F3
holding SEEL Stock option (right to buy) 01 Sep 2021 Common Stock 190,000 $4.31 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on January 27, 2020, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
F2 1/4th of the shares subject to the option shall vest on January 6, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
F3 1/4th of the shares subject to the option shall vest on June 11, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.
F4 1/4th of the shares subject to the option shall vest on March 15, 2022, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney